Director Dealing

RNS Number : 8427V

Physiomics PLC

12 August 2020

 

12 August 2020

Physiomics plc

("Physiomics") or ("the Company")

Director Dealing

The Company announces that it received notice today that Dr Jim Millen sold 597,332 ordinary shares in the Company at 6.45p per share to cover the cost of his exercise of options announced on 5 August 2020.

Following the sale of shares, the total holdings of Dr Jim Millen will be 1,386,947, representing approximately 1.42 per cent. of the Company's issued share capital.

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

Enquiries:

Physiomics plc   

Dr Jim Millen, CEO

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

Strand Hanson Ltd (NOMAD)

Richard Tulloch & James Dance

[phone]

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	James Millen
2	Reason for the notification
a)	Position/status	Director, CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Physiomics plc
b)	LEI	213800A71DSZ6ABMTQ91
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares GB00BDR6W943
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 6.45p 597,332
d)	Aggregated information -  Aggregated volume -  Price	597,332 At 6.45p per share
e)	Date of the transaction	11-8-2020
f)	Place of the transaction	XLON, AIM

 

END

 

 

DSHPBMRTMTJBBFM